Characteristics of patients with non-severe infections of different SARS-CoV-2 omicron subvariants in China

Characteristics of patients with non-severe infections of different SARS-CoV-2 omicron subvariants in China

ObjectiveThe aim of this study was to explore the clinical characteristics of patients infected with different Omicron subvariants presenting non-severe disease, evaluate the safety and efficacy of Azvudine for treatment of COVID-19, in order to broaden understanding of Omicron subvariant infections...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wenfang Yuan, Yongmei Liu, Haoting Zhan, Feng Wei, Qian Zhang, Huixia Gao, Huimin Yan, Tao Huang, Yongzhe Li, Erhei Dai
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Medicine
Subjects:	omicron subvariant BA.2.76 BA.5.1 clinical features Azvudine nucleic acid negativization
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1511227/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Does the COVID-19 XBB Omicron subvariant signal the beginning of the end of the pandemic?
by: Jinghao Nicholas Ngiam, et al.
Published: (2024-12-01)

Two Years of SARS-CoV-2 Omicron Genomic Evolution in Brazil (2022–2024): Subvariant Tracking and Assessment of Regional Sequencing Efforts
by: Ueric José Borges de Souza, et al.
Published: (2025-01-01)

Comparison of immune responses to SARS-CoV-2 spike following Omicron infection or Omicron BA.4/5 vaccination in kidney transplant recipients
by: Inga Tometten, et al.
Published: (2025-01-01)

Design, synthesis, and biological activity evaluation of dihydromyricetin derivatives against SARS-CoV-2-Omicron virus
by: Cong Wu, et al.
Published: (2024-12-01)

Efficacy of azvudine plus dexamethasone in severe hospitalized patients with Omicron infection: a prospective multicenter study
by: Meng-Lan Zhang, et al.
Published: (2024-11-01)

Calceolarioside B inhibits SARS-CoV-2 Omicron BA.2 variant cell entry and modulates immune response
by: Xiao-bin Lin, et al.
Published: (2024-12-01)

Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variantsResearch in context
by: Lok Bahadur Shrestha, et al.
Published: (2024-12-01)

Combined mutations in nonstructural protein 14, envelope, and membrane proteins mitigate the neuropathogenicity of SARS-CoV-2 Omicron BA.1 in K18-hACE2 mice
by: Kotou Sangare, et al.
Published: (2025-01-01)

Surveillance of SARS-CoV-2 variants in Henan, China from 2023 to 2024
by: Yun Song, et al.
Published: (2025-02-01)

Antigenic Imprinting Dominates Humoral Responses to New Variants of SARS-CoV-2 in a Hamster Model of COVID-19
by: Joran Degryse, et al.
Published: (2024-12-01)

Neutralizing Antibody-Mediated Protection from Prior Delta Variant Infection Against Omicron BA.5 Sub-Lineage Reinfection One Year Later: A Prospective Cohort Study
by: Shihan Zhang, et al.
Published: (2024-10-01)

SARS-CoV-2 omicron BA.2.87.1 exhibits higher susceptibility to serum neutralization than EG.5.1 and JN.1
by: Qian Wang, et al.
Published: (2024-12-01)

Multi-omic characteristics of longitudinal immune profiling after breakthrough infections caused by Omicron BA.5 sublineagesResearch in context
by: Yanhua Li, et al.
Published: (2024-12-01)

The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
by: Danyi Ao, et al.
Published: (2023-04-01)

Development of a Recombinant Omicron BA.1 Subunit Vaccine Candidate in Pichia pastoris
by: Sibel Kalyoncu, et al.
Published: (2025-01-01)

Symptoms can predict COVID-19 pneumonia in patients infected with SARS-CoV-2 Omicron variants
by: Qian-Qian Liao, et al.
Published: (2024-12-01)

Prospective clinical performance of CoVarScan in identifying SARS-CoV-2 Omicron subvariants
by: Kenneth Zhu, et al.
Published: (2025-01-01)

Effectiveness of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2.2 Infection in Beijing, China, 2022: A Cohabitation Retrospective Cohort Study
by: Shuaibing Dong, et al.
Published: (2024-12-01)

A novel bispecific antibody targeting two overlapping epitopes in RBD improves neutralizing potency and breadth against SARS-CoV-2
by: Hancong Sun, et al.
Published: (2024-12-01)

Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS)
by: Haruka Maeda, et al.
Published: (2024-12-01)

First-principles calculations to investigate the bulk, electronic, optical and thermoelectric properties of BaGe2As2 and BaGe2P2 alloys
by: Debora Nameme, et al.
Published: (2024-12-01)

Increase of Curie point of BaTiO3 ceramics by stoichiometry, point defects and doping processing
by: Jianquan Qi, et al.
Published: (2025-02-01)

A Critical Look at Shahnameh (1) Shahriyar Namvarnameh (Selected for the Shahnameh Course)
by: Jamileh Akhyani
Published: (2021-11-01)

Considerações sobre espaço urbano e mobilidade intraurbana em Barreiras-BA
by: Bruno Ongaratto, et al.
Published: (2024-08-01)

Immunophenotyping characteristics and clinical outcome of COVID-19 patients treated with azvudine during the Omicron surge
by: Meihua Qiu, et al.
Published: (2024-11-01)

The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity
by: Alba Escalera, et al.
Published: (2024-12-01)

Sustained applicability of SARS-CoV-2 variants identification by Sanger Sequencing Strategy on emerging various SARS-CoV-2 Omicron variants in Hiroshima, Japan
by: Chanroth Chhoung, et al.
Published: (2024-11-01)

Neutralization of omicron subvariants and antigenic cartography following multiple COVID 19 vaccinations and repeated omicron non JN.1 or JN.1 infections
by: Nungruthai Suntronwong, et al.
Published: (2025-01-01)

Towards preliminary inactivated vaccine for SARS CoV-2 isolated from Egypt: ‎Isolation, propagation and inactivation of SARS CoV-2 Omicron variant (in vitro ‎study)‎
by: Mohamed Seadawy, et al.
Published: (2024-08-01)

Integration of Whole-Genome Sequencing with ddPCR Kit for Detection of Omicron Subvariants in Wastewater in the Upper Peninsula of Michigan
by: Michelle M. Jarvie, et al.
Published: (2024-10-01)

Whole genome sequencing analysis of SARS-CoV-2 Omicron variant isolated ‎from Egypt‎
by: Hanaa Ahmed, et al.
Published: (2024-08-01)

Next generation sequencing of multiple SARS-CoV-2 infections in the Omicron Era
by: Marzia Cavalli, et al.
Published: (2025-01-01)

An innovative approach for quality assessment and its contamination on surface water for drinking purpose in Mahanadi River Basin, Odisha of India, with the integration of BA-WQI, AHP-TOPSIS, FL-DWQI, MOORA, and RF methodology
by: Abhijeet Das
Published: (2024-11-01)

Risk of reinfection and severity with the predominant BA.5 Omicron subvariant China, from December 2022 to January 2023
by: Jianpeng Cai, et al.
Published: (2024-12-01)

Sidewall influence of varying free stream Mach number in ramp induced shock wave boundary layer interactions
by: Raja Mangalagiri, et al.
Published: (2024-07-01)

Clinical spectrum of disease and outcomes in children with Omicron SARS-COV-2 infection in Cape Town, South Africa
by: C. Bekker, et al.
Published: (2024-01-01)

The immune landscape and viral shedding of Omicron SARS-CoV-2 variants implicate immune escape
by: Weilong Zhang, et al.
Published: (2025-01-01)

Difference of SARS-CoV-2 infection and influence factors between people with and without HIV infection
by: Jianhui Yang, et al.
Published: (2025-01-01)

Impact of early antiviral therapy on SARS-CoV-2 clearance time in high-risk COVID-19 subjects: A propensity score matching study
by: Marta Colaneri, et al.
Published: (2024-12-01)

Biliary atresia with splenic malformation with associated ductal plate malformation and duodenal atresia: A case report
by: Raktim Mukherjee, et al.
Published: (2024-12-01)